Bill > HR1463

This bill seeks to prohibit the use of any federal funds for implementing, administering, or enforcing a specific Food and Drug Administration (FDA) rule related to Medical Devices and Laboratory Developed Tests (LDTs). The rule in question was submitted for publication in the Federal Register on May 6, 2024, and the bill would prevent any federal money from being used to put this regulation into effect. Laboratory Developed Tests are medical diagnostic tests designed, manufactured, and used within a single laboratory, typically used for detecting or diagnosing specific medical conditions. By preventing federal funding for this rule, the bill effectively blocks the FDA's ability to regulate these tests through the proposed mechanism. The legislation appears to be a direct challenge to the FDA's regulatory approach, suggesting potential concerns about the scope or impact of the proposed rule on laboratory testing practices and medical device oversight.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/1463/all-info